Dimitri Lavillette
Lavillette, Dimitri, 19..-....
VIAF ID: 283906243 (Personal)
Permalink: http://viaf.org/viaf/283906243
Preferred Forms
- 100 0 _ ‡a Dimitri Lavillette
- 100 1 _ ‡a Lavillette, Dimitri, ‡d 19..-....
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
The antimalarial ferroquine is an inhibitor of hepatitis C virus. | |
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs. | |
Cell entry of enveloped viruses. | |
Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps. | |
Characterization of hepatitis C virus pseudoparticles by cryo-transmission electron microscopy using functionalized magnetic nanobeads | |
Co-Infection of Mosquitoes with Chikungunya and Dengue Viruses Reveals Modulation of the Replication of Both Viruses in Midguts and Salivary Glands of Aedes aegypti Mosquitoes | |
Comparative study of chikungunya Virus-Like Particles and Pseudotyped-Particles used for serological detection of specific immunoglobulin M | |
Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity | |
Definition of an amino-terminal domain of the human T-cell leukemia virus type 1 envelope surface unit that extends the fusogenic range of an ecotropic murine leukemia virus | |
Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction | |
Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2. | |
Diverting the assembly properties of heterologous virus to study the life cyle of Hepatitis C. | |
Dynamique de la dengue en Nouvelle-Calédonie : rôle du vecteur Aedes aegypti dans la transmission virale | |
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy | |
The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors | |
Étude de l'entrée du virus du chikungunya et de la réponse de l'hôte à l'infection. | |
Etude des déterminants de la dissémination du virus de la fièvre jaune dans son vecteur Aedes aegytpi | |
The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. | |
The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection | |
Extracellular vesicles from Zika virus‐infected cells display viral E protein that binds ZIKV‐neutralizing antibodies to prevent infection enhancement | |
Flavivirus serological discrimination, study of the Zika virus envelope protein domain III as a target for specific antibodies.. | |
Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model | |
Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth | |
Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer | |
HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses | |
Hepatitis C Virus E1E2 co-evolving networks unveil their functional dialogs and highlight original therapeutic strategies | |
A high-affinity RBD-targeting nanobody improves fusion partner's potency against SARS-CoV-2 | |
Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylation. | |
Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection | |
Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entry | |
Infection of the human testis by emergent viruses : the case of Zika virus and SARS-CoV-2 | |
Interférence entre les virus Chikungunya et Dengue pour l'utilisation de voies cellulaires communes chez les insectes vecteurs lors de co-infection. | |
Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening. | |
A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status. | |
Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patients | |
Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle. | |
The mechanism of HCV entry into host cells | |
Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol | |
Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein | |
N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions | |
Negligible contribution of M2634V substitution to ZIKV pathogenesis in AG6 mice revealed by a bacterial promoter activity reduced infectious clone. | |
Porcine endogenous retroviruses infect cells lacking cognate receptors by an alternative pathway: implications for retrovirus evolution and xenotransplantation | |
A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaques | |
A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes | |
A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism. | |
Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains | |
Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein | |
Les réseaux de co-évolution au sein des protéines E1 et E2 du Virus de l'Hépatite C révèlent leurs dialogues fonctionnels et proposent de nouvelles stratégies thérapeutiques. | |
Retargeting gene delivery using surface-engineered retroviral vector particles. | |
The role of p53 during chikungunya virus infection in mammal and insect | |
The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles | |
The sheep tetherin paralog oBST2B blocks envelope glycoprotein incorporation into nascent retroviral virions | |
Significant redox insensitivity of the functions of the SARS-CoV spike glycoprotein: comparison with HIV envelope. | |
Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients. | |
Study of cellular entry and neutralization of Hepatitis C Virus . | |
A study of yellow fever virus dissemination mechanisms in its vector Aedes aegypti. | |
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee | |
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection | |
The tight junction proteins claudin-1, -6, and -9 are entry cofactors for hepatitis C virus | |
Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody | |
Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection | |
Utilisation des propriétés d'assemblage de virus hétérologues pour l'étude du cycle viral du virus de l'hépatite C | |
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in mice | |
Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infection |